2019 NIAID Omnibus Broad Agency Announcement

This Special Notice announces a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases seeking proposals for the development of radiation and nuclear medical countermeasures. The goal is to support research to develop safe and effective medical countermeasures to mitigate and/or treat tissue injuries from ionizing radiation exposure in a radiological or nuclear incident.

Up to $4 million per year in total funding will be made available for one to two awards to support research to develop medical countermeasures that can effectively treat radiation injuries occurring 24 hours or later after exposure from a radiological or nuclear incident. Proposals must be submitted electronically through the NIAID Contract Proposal Submission website between the anticipated release of funding opportunity announcement number HHS-NIH-NIAID-BAA2019-1 in mid-February 2019 and the associated closing date. The objective is to reduce radiation-associated morbidities and mortalities given that strategic national stockpile drugs may not be mobilized for 24 hours or more after an incident. Awards of up to $4 million per year will be made to one to two contractors demonstrating capabilities to achieve this objective.